AiCuris

Merck wins FDA OK for new CMV drug Prevymis, triggering a $122M payday for AiCuris
Endpoints
Thu, 11/9/17 - 10:06 am
Merck
FDA
CMV
Prevymis
AiCuris
Merck, AiCuris announce publication of letermovir Phase 2 trial results
The Fly on the Wall
Thu, 05/8/14 - 11:18 am
AiCuris
Merck
letermovir
CMV
Merck gets rights to HCMV drug from Bayer spin-off AiCuris
Pharma Times, UK
Mon, 10/15/12 - 11:40 am
Merck
Bayer
AiCuris
HCMV
letermovir